Womb for Adults.

- 0yrs
Pioneering regenerative medicine
- 0M+
Patients treated by team technologies (company-reported)
2029
Targeted first possible investigational treatment
Free
To join the waitlist
Bioelectric Stimulation
Klotho Expression
Regenerative Medicine
Organ-Directed Delivery
Monitored Environment
Klotho Expression
Regenerative Medicine
Organ-Directed Delivery
Monitored Environment
What Lionheart is developing.
Monitored chamber.
A fluid-filled, monitored chamber concept with separate refillable compartments, so researchers can evaluate materials individually before combinations.
Lionheart Octopus™.
A proposed refillable implantable delivery system with organ-directed catheters for studying localized delivery.
Bioelectric signals.
Implantable microstimulators would let researchers study local electrical stimulation alone and alongside biologic delivery.
When and where could it begin?
2029
Roatán, Honduras
Costa Rica
Mexico
2030
Dubai, United Arab Emirates
Lithuania
The Bahamas
2031
United States
Join the waitlist.
Read our Privacy Policy. We collect only your email and optional location.
Joining the waitlist expresses interest. Any future study will have its own eligibility, screening and consent process. A signup does not reserve a place or guarantee treatment.
Frequently asked questions.
Study applications are currently closed. If applications open, we’ll share the study details, eligibility criteria and how to apply.
You’ll be among the first to hear if applications open. The study team will determine eligibility through a separate screening process.
You can tell us which location you’d like to hear about. We’ll share the first study location when it’s confirmed.
Waitlist signup is free. You won’t be asked for payment information.